Ophthalmic Therapeutic Innovation LLC, 2025-12-02
An SEC Form D private-offering notice from Watertown, MA, a $300,000 filer-stated offering target in Biotech. Filed 2025-12-02. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Ophthalmic Therapeutic Innovation is a clinical stage biotech developing an eye drop therapy intended to normalize eye pressure and treat glaucoma related nerve damage.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Odyssey Therapeutics, Inc., 2025-12-04, $214M, Boston, MA
- Protego Biopharma, Inc., 2025-12-03, $130.4M, San Diego, CA
- Paretor LLC, 2025-12-03, $105K, Watertown, MA
- ADIAL PHARMACEUTICALS, INC., 2025-12-03, $4.3M, Glen Allen, VA
- Corista, LLC, 2025-12-03, $20.1M, Concord, MA
- Akura Medical, Inc., 2025-12-03, $72M, Campbell, CA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.